SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 24.91-1.7%Dec 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (14686)9/17/2000 9:07:33 AM
From: Robert K.  Read Replies (1) of 17367
 
Cacaito, before you stick up for the FDA and their so-called standards, read this carefully and tell me whats wrong with this picture.>>>>
Read this...just approved this friday>>>>>>>>>>
>>>>>>>>"For serious illnesses where patients need access to new medications, the FDA allows accelerated approval based on data from ongoing studies."
". At present, there are no results from controlled trials evaluating the effect of Kaletra on the progression of HIV. Full approval is granted based on review of additional safety and efficacy data from Phase III clinical trials."
The link>http://biz.yahoo.com/prnews/000915/il_abbott__2.html
So in fact, the fDA is compassionate for HIV,
sure looks to me like the FDA standards dropped quite a bit for this open label trial.
DAMN IT, GIVE THE KIDS A OPEN LABEL STUDY.
>All just IMO, standard disclaimers
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext